Article
Application of CRISPR/Cas9-Mediated Genome Editing in Leishmania.
Methods in molecular biology (Clifton, N.J.) - 1 Jan 2020
Zhang Wen-Wei, Lypaczewski Patrick, Matlashewski Greg
Abstract excerpt
CRISPR-Cas9 is an RNA guided endonuclease derived from the bacterium Streptococcus pyogenes. Due to its simplicity, versatility, and high efficiency, it has been widely used for genome editing in a variety of organisms including the protozoan parasite Leishmania, the causative agent of human leishmaniasis. Compared to the traditional homologous recombination gene targeting method, CRISPR-Cas9 has been shown to be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
